Skip to content

Drug interactions

Ethosuximide + Istradefylline

Severity: Minor

Ethosuximide and Istradefylline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Istradefylline at higher doses (40 mg/day) weakly inhibits CYP3A4 and can increase exposure to CYP3A4 substrates. Ethosuximide exposure may rise modestly, increasing sedation or gastrointestinal effects.

What this interaction means in plain words

Ethosuximide and Istradefylline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ethosuximide belongs to Central Nervous System; Istradefylline belongs to Central Nervous System.

Evidence level: Low

Why it happens

Dose-dependent CYP3A4 inhibition by istradefylline reducing ethosuximide clearance.

What to do

Monitor for ethosuximide toxicity if istradefylline is used at 40 mg/day, and consider ethosuximide dose reduction if adverse effects occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethosuximide and Istradefylline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethosuximide with Istradefylline?

MediHelp rates the interaction as minor. Ethosuximide and Istradefylline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Istradefylline at higher doses (40 mg/day) weakly inhibits CYP3A4 and can increase exposure to CYP3A4 substrates. Ethosuximide exposure may rise modestly, increasing sedation or gastrointestinal effects.

How serious is the interaction between Ethosuximide and Istradefylline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide toxicity if istradefylline is used at 40 mg/day, and consider ethosuximide dose reduction if adverse effects occur.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in